Mondragón CA, García OE, Barroso MA

Language: Spanish
References: 10
Page: 69-74
PDF size: 107.53 Kb.

ABSTRACT

Introduction: the World Health Organization (WHO) in 1971 reported that 6.7 units were required per patient bed per year to satisfy the transfusion needs of a hospital. Evaluations of consumption of blood components for inappropriate medical indications showed prevalence of 40% (Israel) to 11% (USA).
Objectives: to identify prevalence of factors that increase consumption of blood components at the Regional General Hospital 1 of the Instituto Mexicano del Seguro Social (IMSS), Morelos, State, Mexico.
Materials and methods: this is a descriptive, observational, retrospective, transverse trial. The trial was carried out at the Regional General Hospital 1 IMSS and assessed 280 blood units used during 2001 for policyholders. Information was collected by questionnaire and sought data on medical indication supported by worldwide literature criteria, management during application, and adverse reactions, supported by the Norma Oficial Mexicana.
Results: we found that inadequate medical indication was observed in 41.1 % cases; elimination due to inappropriate management was 0 % and only one blood unit caused an adverse reaction (0.36 %).
Conclusions: prevalence of inappropriate medical indication was more than that found in the world literature, this being a factor associated with consumption. Waste due to incorrect handling and adverse reaction, below that expected, indicated that there was no real notification.

REFERENCES

1. Lyons-Petrucelli A. Historia de la hematología En: Lyons-Petrucelli A. Historia de la medicina. Barcelona, España Doyma; 1989. p. 587-589.

2. Ruiz-Argüelles G. Transfusiones . En: Ruiz-Argüelles G. Fundamentos de hematología. Bogotá, Colombia: Panamericana; 1994. p. 239-255.

3. Seymour IS. Hemostasia. En: Seymour IS. Manual de principios de cirugía. México: Interamericana-McGraw- Hill; 1994. p. 32-34.

4. Norma oficial para disposición sangre y hemoderivados. México: Secretaría de Salud; 1994. p. 10-74.

5. Fopp FM. Factors associated with transfusion requeriments during treatment for acute myelogenous leukemia Hematology 1997;67:153-160.

6. McCullough J, Steeper TA. Platelet utilization in a university hospital. JAMA 1988;259(16):2414-2416.

7. Mozes B, Epstein M. Evaluation of the appropriateness of blood and blood product transfusion using preset criteria. Transfusion 1989;29(6):473-476.

8. Coffin C, Matz K. Algorithms for evaluating the appropiateness of blood Transfusion 1989;29(4):298-303.

9. Stites PD. Inmunología básica y clínica. México: El Manual Moderno; 1993. p. 319-328.

10. Subdirección General, Jefatura de los Servicios Universitarios. Curso de capacitación en diseño experimental y estadística. México: IMSS; 1996. p. 47.